Panagiotis Konstantinopoulos

Dana-Farber Cancer Inst

$4,290,380

Attributed

$5,677,527

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY2020–25

$5M$3.8M$2.5M$1.3M$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$11,604,563 · 5

By mechanism

P01$7,053,341 · 2

R01$2,774,294 · 1

P50$1,776,928 · 2

Top collaborators

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Tumor”

Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213

Research focus

TumorResponseMalignant NeoplasmsChemotherapyGenomicsExhibitsBiological MarkersMalignant Neoplasm Of OvarySynergismPathway InteractionsRecurrenceMouse ModelPlatinumOrganoidsTranscriptome SequencingDesignMutateNeoplastic CellGeneticCancer CellCancer Cell LineIn VivoInhibitorPatient Derived Xenograft Model